Research National Research Program Strategic Ecosystem Partnership Grant recipients

Strategic Ecosystem Partnership Grant recipients

Read an overview of the SERP Grant projects that we’re currently funding.

High-precision testing of single cells with cutting-edge imaging

Improving the Safety and Efficacy of Chimeric Antigen Receptor (CAR) T Cell Therapies

Picture of scientist Melissa Call from WEHI

A better diagnosis system for AL amyloidosis

Impact of Frailty on Treatment and healthcare: improving quality of life for older MDS/AML patients

Multiomic analysis in Waldenstrom’s Macroglobulinemia

Developing state-of-the art molecular genomic testing in cancer diagnosis and monitoring

New prognostic score for Follicular Lymphoma to rationalise therapeutic decision-making and improve patient outcomes

Deep profiling of ALL and myeloma for targeted therapies

Understanding the process of progression from MDS to acute leukaemia

Characterisation of a novel DCAF factor as a blood cancer therapy

Precision Medicine in acute lymphoblastic leukaemia

The Centre for Blood Transplant and Cell Therapy

SERP project archive

2012

Prof Andrew Zannettino, Prof Peter Croucher, Dr Kyohei Nakamura – The role of the bone marrow microenvironment in the myeloma plasma cell dormancy and reactivation – toward a cure for myeloma

Last updated on November 22nd, 2024

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.